Clinical Trial Update: Rho Kinase Inhibitor in Amyotrophic Lateral Sclerosis (REAL) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a rho kinase inhibitor for amyotrophic lateral sclerosis is underway but currently not recruiting participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Rho-kinase inhibitor

Snippet

Sponsor: Woolsey Pharmaceuticals | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: ACTIVE_NOT_RECRUITING